Sitemap
Pages
Posts
- Ben Watt Joins SERB and BTG as Group CFO
- SERB acquires the rights to Xermelo® outside US and Japan for Carcinoid Syndrome Diarrhoea
- SERB acquires Veriton Pharma
- SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines
- SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity